Article Details

Adaptive Biotech Teams Up With NeoGenomics To Advance MRD Monitoring Options

Retrieved on: 2025-01-14 17:12:07

Tags for this article:

Click the tags to see associated articles and topics

Adaptive Biotech Teams Up With NeoGenomics To Advance MRD Monitoring Options. View article details on hiswai:

Summary

Adaptive Biotechnologies and NeoGenomics have partnered to enhance minimal residual disease monitoring in leukemia through Adaptive's clonoSEQ and NeoGenomics' assessment services. This collaboration leverages biotech innovations in oncology to improve cancer management.

Article found on: www.rttnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up